Annals of Hepato-Biliary-Pancreatic Surgery (한국간담췌외과학회지)

The Korean Association of Hepato-Biliary-Pancreatic Surgery (한국간담췌외과학회)
권호 표지
DOI QR코드

DOI QR Code

Curative intent radical cholecystectomy followed by hyperthermic intraperitoneal chemotherapy in ruptured intraductal papillary neoplasm of gallbladder with invasive carcinoma

  • Gyeonggyu Choi (Yonsei University College of Medicine) ;
  • Seokwon Jang (Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine) ;
  • Munseok Choi (Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine) ;
  • Seungyoon Yang (Division of Colorectal Surgery, Department of Surgery, Yonsei University College of Medicine) ;
  • Chunggeun Lee (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Chang Moo Kang (Yonsei University College of Medicine)
  • Received : 2021.05.21
  • Accepted : 2021.08.09
  • Published : 2022.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Gallbladder cancer has a poor prognosis, especially in peritoneal carcinomatosis related to perforation of the gallbladder followed by bile spillage. Previously, curative-intent treatment was not considered in carcinomatosis from cancer of the biliary tract. A 72-year-old male was referred to the hospital with a perforated gallbladder cancer. Intraoperatively, the tumor was confined to the gallbladder and liver. We presented a case of intention-to-curative resection of perforated gallbladder cancer followed by intraoperative hyperthermic intraperitoneal chemotherapy.

Keywords

References

  1. Kim YJ, Kim K. Conditional survival in patients with gallbladder cancer. Chin J Cancer 2017;36:85. 
  2. Nishio H, Nagino M, Ebata T, Yokoyama Y, Igami T, Nimura Y. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepatobiliary Pancreat Surg 2007;14:351-357. 
  3. van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 2018;378:230-240. 
  4. Vanounou T, Garfinkle R. Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin in the era of value-based medicine. Ann Surg Oncol 2016;23:2556-2561. 
  5. Goere D, Passot G, Gelli M, Levine EA, Bartlett DL, Sugarbaker PH, et al. Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI). Int J Hyperthermia 2017;33:520-527. 
  6. Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 2010;116:5608-5618. 
  7. Levine EA, Stewart JH 4th, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg 2007;204:943-953; discussion 953-955. 
  8. Glockzin G, Renner P, Popp FC, Dahlke MH, von Breitenbuch P, Schlitt HJ, et al. Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2011;18:1052-1059. 
  9. Rocha FG, Lee H, Katabi N, DeMatteo RP, Fong Y, D'Angelica MI, et al. Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology 2012;56:1352-1360. 
  10. Nakanuma Y, Kakuda Y, Uesaka K. Characterization of intraductal papillary neoplasm of the bile duct with respect to the histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm. Gut Liver 2019;13:617-627. 
  11. Wasif N, Bentrem DJ, Farrell JJ, Ko CY, Hines OJ, Reber HA, et al. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes. Cancer 2010;116:3369-3377. 
  12. Choi M, Chong JU, Hwang HK, Seo HI, Yang K, Ryu JH, et al. Role of postoperative adjuvant therapy in resected invasive intraductal papillary mucinous neoplasm of the pancreas: a multicenter external validation. J Hepatobiliary Pancreat Sci 2021. https://doi.org/10.1002/jhbp.996 [in press] 
  13. Bennett S, Marginean EC, Paquin-Gobeil M, Wasserman J, Weaver J, Mimeault R, et al. Clinical and pathological features of intraductal papillary neoplasm of the biliary tract and gallbladder. HPB (Oxford) 2015;17:811-818. 
  14. Castelo Branco M, Estevinho F, Correia Pinto J, Honavar M, Raposo C, Silva AC, et al. Gallbladder cancer: complete resection after second line treatment in stage IV disease. J Gastrointest Cancer 2019;50:564-567. 
  15. Kuga D, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, et al. Long-term survival after multidisciplinary therapy for residual gallbladder cancer with peritoneal dissemination: a case report. Surg Case Rep 2017;3:76. 
  16. Kang MJ, Song Y, Jang JY, Han IW, Kim SW. Role of radical surgery in patients with stage IV gallbladder cancer. HPB (Oxford) 2012;14:805-811. 
  17. Randle RW, Levine EA, Clark CJ, Stewart JH, Shen P, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gallbladder cancer: a retrospective review. Am Surg 2014;80:710-713. 
  18. Kwon W, Kim H, Han Y, Hwang YJ, Kim SG, Kwon HJ, et al. Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study. Br J Surg 2020;107:1334-1343. 
  19. Yuza K, Sakata J, Prasoon P, Hirose Y, Ohashi T, Toge K, et al. Long-term outcomes of surgical resection for T1b gallbladder cancer: an institutional evaluation. BMC Cancer 2020;20:20. 
  20. Navarro JG, Kang I, Hwang HK, Yoon DS, Lee WJ, Kang CM. Oncologic safety of laparoscopic radical cholecystectomy in pT2 gallbladder cancer: a propensity score matching analysis compared to open approach. Medicine (Baltimore) 2020;99:e20039.